CH593303A5 - - Google Patents

Info

Publication number
CH593303A5
CH593303A5 CH796273A CH796273A CH593303A5 CH 593303 A5 CH593303 A5 CH 593303A5 CH 796273 A CH796273 A CH 796273A CH 796273 A CH796273 A CH 796273A CH 593303 A5 CH593303 A5 CH 593303A5
Authority
CH
Switzerland
Application number
CH796273A
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US259092A external-priority patent/US3862193A/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of CH593303A5 publication Critical patent/CH593303A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH796273A 1972-06-02 1973-06-01 CH593303A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US259092A US3862193A (en) 1970-12-02 1972-06-02 O-(nitroaryl) oximes of 3-keto steroids

Publications (1)

Publication Number Publication Date
CH593303A5 true CH593303A5 (en:Method) 1977-11-30

Family

ID=22983493

Family Applications (1)

Application Number Title Priority Date Filing Date
CH796273A CH593303A5 (en:Method) 1972-06-02 1973-06-01

Country Status (9)

Country Link
BE (1) BE800405R (en:Method)
CA (1) CA998041A (en:Method)
CH (1) CH593303A5 (en:Method)
DE (1) DE2327509A1 (en:Method)
FR (1) FR2186263B2 (en:Method)
GB (1) GB1429951A (en:Method)
IL (3) IL42423A (en:Method)
NL (1) NL7307703A (en:Method)
ZA (1) ZA733706B (en:Method)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211756A (en) * 1963-07-23 1965-10-12 Searle & Co 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding
US3686237A (en) * 1969-12-04 1972-08-22 Ortho Pharma Corp O-(nitroaryl)oximes of 3-keto steroids

Also Published As

Publication number Publication date
IL42423A (en) 1977-02-28
AU5642873A (en) 1974-12-05
GB1429951A (en) 1976-03-31
IL50345A (en) 1977-02-28
CA998041A (en) 1976-10-05
IL42423A0 (en) 1973-08-29
FR2186263A2 (en:Method) 1974-01-11
BE800405R (fr) 1973-12-03
IL50345A0 (en) 1976-10-31
FR2186263B2 (en:Method) 1976-08-13
DE2327509A1 (de) 1973-12-13
ZA733706B (en) 1975-01-29
NL7307703A (en:Method) 1973-12-04

Similar Documents

Publication Publication Date Title
JPS4972573A (en:Method)
JPS4939621A (en:Method)
FR2187529B1 (en:Method)
JPS5114055B2 (en:Method)
JPS4963235A (en:Method)
JPS4930570U (en:Method)
CS157313B1 (en:Method)
JPS4950234A (en:Method)
JPS5256776Y2 (en:Method)
FR2186263B2 (en:Method)
AU465382B2 (en:Method)
AU4040772A (en:Method)
JPS4965033U (en:Method)
JPS4969270U (en:Method)
JPS4956933U (en:Method)
JPS4892540U (en:Method)
CH580055A5 (en:Method)
BG18288A1 (en:Method)
CH563649A5 (en:Method)
CH585796A5 (en:Method)
CH585164A5 (en:Method)
CH584728A5 (en:Method)
CH583040A5 (en:Method)
CH562919A5 (en:Method)
CH579611A5 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased